<DOC>
	<DOCNO>NCT00836641</DOCNO>
	<brief_summary>Asthma major health problem preschool child . Infections pneumococci frequent cause airway infection , tend cause worsen asthma . Vaccination pneumococcus recommend scientific board medical community , order reduce burden disease . Data immunogenicity safety pneumococcal immunization preschool asthmatic scarce .</brief_summary>
	<brief_title>Safety Immunogenicity Sequential Pneumococcal Immunization Preschool Asthmatics</brief_title>
	<detailed_description>Respiratory infection major trigger exacerbation preschool asthma . Many country ' guideline recommend immunization pneumococcus patient suffer chronic airway disease . Also interval prim booster matter debate . We immunize large group preschool asthmatic ( 2-5 year old ) sequentially : one dose seven-valent pneumococcal conjugate vaccine ( PCV-7 ) follow single dose 23-valent pneumococcal polysaccharide vaccine ( PPV-23 ) . We randomly assign half vaccinee receive PPV-23 eight week PCV-7 ( group A ) , rest 10-month interval ( group B ) . Pneumococcal antibody concentration serotype 4 , 5 , 6B , 7 , 9V , 14 , 18c , 19F , 23F determine initially , two , 12 month PCV-7 . Local systemic reaction vaccine record .</detailed_description>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>asthma classify accord Global Initiative Asthma ( GINA ) Â°12 antecedent pneumococcal immunization</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>preschool asthma</keyword>
	<keyword>sequential pneumococcal immunization</keyword>
	<keyword>immunogenicity</keyword>
	<keyword>safety</keyword>
</DOC>